0001415889-24-017241.txt : 20240617
0001415889-24-017241.hdr.sgml : 20240617
20240617170023
ACCESSION NUMBER: 0001415889-24-017241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240617
DATE AS OF CHANGE: 20240617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: William Arsani
CENTRAL INDEX KEY: 0001848372
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 241049098
MAIL ADDRESS:
STREET 1: C/O DESIGN THERAPEUTICS, INC.
STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
4
1
form4-06172024_050620.xml
X0508
4
2024-06-13
0001807120
Design Therapeutics, Inc.
DSGN
0001848372
William Arsani
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
true
false
false
false
0
Stock Option (right to buy)
3.82
2024-06-13
4
A
0
19000
0
A
2034-06-12
Common Stock
19000
19000
D
The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.
/s/ Mustapha Parekh, Attorney-in-Fact
2024-06-17